Andrew Regan - Director, 10%+ Owner at Conduit Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
CDT, CDTTW on Nasdaq
All Insider Reports
All Insider Reports

Andrew Regan - trading volume in the past year for Conduit Pharmaceuticals Inc.

Holdings reported by Andrew Regan for Conduit Pharmaceuticals Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 178K $45.9K $0.26 Jul 17, 2024 Indirect
Common Stock 66.7K $17.2K $0.26 Jun 14, 2024 Direct
Common Stock, par value $0.0001 per share ("Shares") 66.7K Sep 22, 2023 Direct

Transactions reported by Andrew Regan for Conduit Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.